Confirmatory IHC showed expression of both ALK and mutation-specific EGFR-L858R protein in the same tumor cells, despite the generally mutually exclusive occurrences of driver mutations in treatment-naïve lung cancers18–20 (Fig. 1a and Supplementary Fig. 1). The gene discussed is EGFR; the disease is neoplasm.